Multicenter, Randomized, Non-comparative, Controlled Study of Therapeutic Intensification Plus Immunomodulation in HIV-infected Patients With Long-term Viral Suppression.

Trial Profile

Multicenter, Randomized, Non-comparative, Controlled Study of Therapeutic Intensification Plus Immunomodulation in HIV-infected Patients With Long-term Viral Suppression.

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Sep 2014

At a glance

  • Drugs HIV DNA vaccine (Primary) ; Maraviroc (Primary) ; Raltegravir (Primary) ; V 520 (Primary)
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Acronyms EraMune-02
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 11 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 30 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top